BioSpace News Archive

Business

Alloy and Pyxis Take Aim at Cancer, Autoimmune Diseases with New Joint Venture

Thanks to a recent joint venture, there is a new company taking on cancer and autoimmune diseases.

May 25, 2021
·
2 min read
·
Ellen Bombela
BioMidwest

NorthStar Medical Radioisotopes Enters U.S. Supply Agreement for Commercial Supply of Therapeutic Radioisotope Copper-67 (Cu-67) Exclusively to Clarity Pharmaceuticals for Its Targeted Copper Theranostics Programs

Master Supply Agreement encompasses clinical development and commercial supply for Clarity’s Cu-67-based candidates to treat neuroblastoma, breast and prostate cancers, among others

May 25, 2021
·
6 min read
Business

Burning Rock Reports First Quarter 2021 Financial Results

Burning Rock Biotech Limited, a company focused on the application of next generation sequencing technology in the field of precision oncology, reported financial results for the three months ended March 31, 2021.

May 25, 2021
·
15 min read
Number of Shares and Voting Rights of Innate Pharma as of May 1, 2021

Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities General Regulation, Innate Pharma SA releases its total number of shares outstanding as well as its voting rights as of May 1, 2021

May 25, 2021
·
4 min read
Drug Development

Nordic Nanovector Announces Update from Archer-1 Phase 1b Trial of Betalutin® in combination with rituximab in 2L Follicular Lymphoma

Nordic Nanovector ASA announces initial promising data from the Archer-1 Phase 1b trial investigating Betalutin® in combination with rituximab in second-line follicular lymphoma.

May 25, 2021
·
5 min read
Drug Development

Oncopeptides AB: Phase 3 OCEAN study demonstrates that melflufen is at least as efficacious as pomalidomide, the most used medicine in relapsed refractory multiple myeloma

Melflufen and pomalidomide had similar discontinuation rates for adverse events, and the safety profile of melflufen was in line with previous studies

May 25, 2021
·
8 min read
Bio NC

Verona Pharma to Present at Jefferies Virtual Healthcare Conference - May 25, 2021

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and President, will present a company overview at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 9:00 AM ET.

May 25, 2021
·
2 min read
Pharm Country

Tiziana Life Sciences Announces Initiation of Clinical Trial in a SPMS Patient with Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program

The first patient with SPMS was dosed on May 24, 2021 with nasally administered Foralumab. The treatment regimen will continue for six months to examine long-term safety, tolerability and clinical responses.

May 25, 2021
·
6 min read
Kioxia Earns 2021 Invention Prize from the National Commendation for Invention

Kioxia Corporation, a world leader in memory solutions, announced that it was awarded the 2021 Invention Prize from the National Commendation for Invention of semiconductor flash memory extension-of-life-span technology.

May 25, 2021
·
2 min read
Proliferative Diabetic Retinopathy Market: Rising Incidence of Diabetes to Propel Market Demand

The demand within the global market for proliferative diabetic retinopathy has been rising on account of the growing incidence of diabetes across the globe, finds Transparency Market Research.

May 25, 2021
·
4 min read